Impact of Early Diagnosis and Intravenous Immunoglobulin on the Health-Related Quality of Life of Primary Immune Deficiency Children

Authors

  • Salim Zridi Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
  • Islam Mansouri Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
  • Fatima Ailal  Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco. &  Department of pediatric infectious and immunological diseases, Abderrahim El Harouchi Children Hospital, University Hospital Center Ibn Rochd, Casablanca, Morocco.
  • Ibtihal Benhsaiene  Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco. &  Department of pediatric infectious and immunological diseases, Abderrahim El Harouchi Children Hospital, University Hospital Center Ibn Rochd, Casablanca, Morocco.
  • Jalila El Bakkouri Immunology Laboratory, IBN Rochd University Hospital, Casablanca, Morocco.
  • Ahmed Aziz Bousfiha Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco. & Department of pediatric infectious and immunological diseases, Abderrahim El Harouchi Children Hospital, University Hospital Center Ibn Rochd, Casablanca, Morocco.

DOI:

https://doi.org/10.55677/IJCSMR/V3I10-02/2023

Keywords:

PID, IEI, QOL, HRQOL of children.

Abstract

 

Background: Inborn errors of immunity (IEI) are rare hereditary genetic, with around 485 rare immune system defects. Health-Related Quality of life (HRQOL) of children and adolescents with IEI is influenced by the early diagnosis of the disease, Immunoglobulin replacement, type of IEI, socio-economic status, family, social support, medical et social environment. Little attention is given to the HRQOL of patients, health professionals and stakeholders tend to focus on medical treatment more than the other aspect of the quality of life. The objective of this study is to measure the improvement of the HRQOL after the diagnosis and the Immunoglobin treatment of IEI patients in Morocco.

Results: Total HRQOL was improved after diagnosis and treatment administration (Ig therapy) for the two groups of IEI patients using the generic EQ-5D-Y instrument (p = 0.0009). The improvement was most significant in the physical domain, financial, and schooling domains using the KIDSCREEN-52 instrument.

Conclusions: Health-Related Quality of Life plays a major role in health care; it gives insights into the factors that may improve the provision of health services.

References

Aghamohammedi, et al. (2011). Health-related quality of life in primary antibody deficiency, Iran J. Allergy Asthma Immunol, 47–51.

B. Ataeinia, A. M. (2017). Measurement of health-related quality of life in primary antibody-deficient patients. Immunol. Investig., 329–340.

Detmar, S. B.-S. (2006). The use of focus groups in the development of the KIDSCREEN HRQL questionnaire. Quality of Life Research, 15, 1345–1353. doi:https://doi.org/10.1007/s11136-006-0022-z

John T. Anderson, J. C.-N. (2022). Health-related quality of life in primary immunodeficiencies. journal of clinical immunology, 1521-6616.

McDougall, J. B. (2016). Quality of life and self-determination: youth with chronic health conditions make the connection. Applied Research in Quality of Life, 11(2), 571–599.

doi:https://doi.org/10.1007/s11482-014-9382-7.

P. Titman, Z. A.-P. (2014). Quality of life in children with primary antibody deficiency. J. Clin. Immunol, 844–852. doi:DOI 10.1007/s10875-014-0072-x

Pardo-Guijarro MJ, W. B.-M.-A.-V. (2013). Validity and reliability of the Spanish sign language version of the KIDSCREEN-27 health-related quality of life questionnaire for use in deaf children and adolescents. Gac Sanit 27, (4):318–324.

Ravens-Sieberer, U. A. (2007). The KIDSCREEN-27 quality of life measure for children and adolescents: psychometric results from a cross-cultural survey in 13 European countries. Quality of Life Research, 16, 1347–1356. doi: https://doi.org/10.1007/s11136-007-9240-2.

S. Kearns, L. K. (2017). Clinical profile, dosing, and quality-of-life outcomes in primary immune deficiency patients treated at home with immunoglobulin G: data from the IDEaL patient registry. J. Manag. Care Spec. Pharm, 400–406.

Stuart G. Tangye, W. H. A. R. (2022). Human Inborn Errors of Immunity: 2022 Update on the Classifcation from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology, n.d. doi:https://doi.org/10.1007/s10875-022-01289-3.

WHO. (1998). The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Social Science and Medicine, 46, 1569–1585. doi:https://doi.org/10.1016/S0277-9536(98)00009-4

Wong CKH, C. P. (2019). A head-to-head comparison of five-level (EQ-5D-5L-Y) and three-level EQ-5D-Y questionnaires in paediatric patients. Eur J Health Econ, 20(5):647–656.

Downloads

Published

2023-10-24

How to Cite

Salim Zridi, Islam Mansouri, Fatima Ailal, Ibtihal Benhsaiene, Jalila El Bakkouri, & Ahmed Aziz Bousfiha. (2023). Impact of Early Diagnosis and Intravenous Immunoglobulin on the Health-Related Quality of Life of Primary Immune Deficiency Children. International Journal of Clinical Science and Medical Research, 3(10), 191–197. https://doi.org/10.55677/IJCSMR/V3I10-02/2023